尿失禁治療デバイスの世界市場 (2022年～2031年)：製品 (尿道スリング・電気刺激デバイス・人工尿道括約筋・カテーテル) 別の産業分析・規模・シェア・成長・動向・予測

当レポートでは、世界の尿失禁治療デバイスの市場を調査し、市場概要、市場成長への各種影響因子の分析、規制・償還シナリオ、技術動向、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 序文

第2章 前提・調査手法

第3章 エグゼクティブサマリー：世界の尿失禁治療デバイス市場

第4章 市場概要

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• 世界の尿失禁治療デバイス市場の分析と予測

第5章 主な洞察

• 技術の進歩
• 尿失禁の有病率：主要地域別
• 規制および償還シナリオ：国/地域別
• COVID-19影響分析

第6章 世界の尿失禁治療デバイス市場の分析・予測：製品別

• イントロダクション・定義
• 主な調査結果/展開
• 市場予測
  • 尿道スリング
  • 電気刺激デバイス
  • 人工尿道括約筋
  • カテーテル
• 市場の魅力

第7章 世界の尿失禁治療デバイス市場の分析・予測：失禁タイプ別

• イントロダクション・定義
• 主な調査結果/展開
• 市場予測
  • 腹圧性尿失禁
  • 切迫性尿失禁
  • 混合失禁
  • 溢流性尿失禁
• 市場の魅力

第8章 世界の尿失禁治療デバイス市場の分析・予測：エンドユーザー別

• イントロダクション・定義
• 主な調査結果/展開
• 市場予測
  • 病院
  • 外来手術センター
  • 診療所
  • 家庭用
• 市場の魅力

第9章 世界の尿失禁治療デバイス市場の分析・予測：地域別

• 主な調査結果
• 市場予測
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ
• 市場の魅力

第10章 北米の尿失禁治療デバイス市場の分析・予測

第11章 欧州の尿失禁治療デバイス市場の分析・予測

第12章 アジア太平洋の尿失禁治療デバイス市場の分析・予測

第13章 ラテンアメリカの尿失禁治療デバイス市場の分析・予測

第14章 中東およびアフリカの尿失禁治療デバイス市場の分析・予測

第15章 競合情勢

• 参入企業：競合マトリックス
• 企業シェア分析
• 企業プロファイル
  • CR Bard, Inc.（Becton, Dickinson and Company）
  • Coloplast Group
  • Promedon Group
  • AMI GmbH
  • Ethicon US, LLC.（Johnson &Johnson）
  • ZSI Surgical Implants SRL
  • Medtronic plc
  • InControl Medical LLC
  • Hollister Incorporated
  • Atlantic Therapeutics Group Ltd.
  • B. Braun Melsungen AG
  • Teleflex Incorporated

List of Tables

• Table 01: Global Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Product, 2017-2031
• Table 02: Global Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Incontinence Type, 2017-2031
• Table 03: Global Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
• Table 04: Global Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Region, 2017-2031
• Table 05: North America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Country, 2017-2031
• Table 06: North America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Product, 2017-2031
• Table 07: North America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Incontinence Type, 2017-2031
• Table 08: North America Urinary Incontinence Treatment Devices Market (US$ Mn) Forecast, by End-user, 2017-2031
• Table 09: Europe Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
• Table 10: Europe Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Product, 2017-2031
• Table 11: Europe Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Incontinence Type, 2017-2031
• Table 12: Europe Urinary Incontinence Treatment Devices Market (US$ Mn) Forecast, by End-user, 2017-2031
• Table 13: Asia Pacific Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
• Table 14: Asia Pacific Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Product, 2017-2031
• Table 15: Asia Pacific Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Incontinence Type, 2017-2031
• Table 16: Asia Pacific Urinary Incontinence Treatment Devices Market (US$ Mn) Forecast, by End-user, 2017-2031
• Table 17: Latin America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
• Table 18: Latin America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Product, 2017-2031
• Table 19: Latin America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Incontinence Type, 2017-2031
• Table 20: Latin America Urinary Incontinence Treatment Devices Market (US$ Mn) Forecast, by End-user, 2017-2031
• Table 21: Middle East & Africa Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
• Table 22: Middle East & Africa Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Product, 2017-2031
• Table 23: Middle East & Africa Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Incontinence Type, 2017-2031
• Table 24: Middle East & Africa Urinary Incontinence Treatment Devices Market (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

• Figure 01: Global Urinary Incontinence Treatment Devices Market, by Product, 2021 and 2031
• Figure 02: Global Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Product, 2022-2031
• Figure 03: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Urethral Slings, 2017-2031
• Figure 04: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Electrical Stimulation Devices, 2017-2031
• Figure 05: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Artificial Urinary Sphincters, 2017-2031
• Figure 06: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Catheters, 2017-2031
• Figure 07: Global Urinary Incontinence Treatment Devices Market, by Incontinence Type, 2021 and 2031
• Figure 08: Global Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Incontinence Type, 2022-2031
• Figure 09: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Stress Urinary Incontinence, 2017-2031
• Figure 10: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Urge Urinary Incontinence, 2017-2031
• Figure 11: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Mixed Incontinence, 2017-2031
• Figure 12: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Overflow Incontinence, 2017-2031
• Figure 13: Global Urinary Incontinence Treatment Devices Market, by End-user, 2021 and 2031
• Figure 14: Global Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by End-user, 2022-2031
• Figure 15: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Hospitals, 2017-2031
• Figure 16: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Ambulatory Surgery Centers, 2017-2031
• Figure 17: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Clinics, 2017-2031
• Figure 18: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Home Use, 2017-2031
• Figure 19: Global Urinary Incontinence Treatment Devices Market Value Share Analysis, by Region, 2021 and 2031
• Figure 20: Global Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Region, 2022-2031
• Figure 21: North America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, 2017-2031
• Figure 22: North America Urinary Incontinence Treatment Devices Market Value Share Analysis, by Country, 2021 and 2031
• Figure 23: North America Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Country, 2022-2031
• Figure 24: North America Urinary Incontinence Treatment Devices Market, by Product, 2021 and 2031
• Figure 25: North America Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Product, 2022-2031
• Figure 26: North America Urinary Incontinence Treatment Devices Market, by Incontinence Type, 2021 and 2031
• Figure 27: North America Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Incontinence Type, 2022-2031
• Figure 28: North America Urinary Incontinence Treatment Devices Market, by End-user, 2021 and 2031
• Figure 29: North America Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by End-user, 2022-2031
• Figure 30: Europe Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, 2017-2031
• Figure 31: Europe Urinary Incontinence Treatment Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
• Figure 32: Europe Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
• Figure 33: Europe Urinary Incontinence Treatment Devices Market, by Product, 2021 and 2031
• Figure 34: Europe Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Product, 2022-2031
• Figure 35: Europe Urinary Incontinence Treatment Devices Market, by Incontinence Type, 2021 and 2031
• Figure 36: Europe Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Incontinence Type, 2022-2031
• Figure 37: Europe Urinary Incontinence Treatment Devices Market, by End-user, 2021 and 2031
• Figure 38: Europe Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by End-user, 2022-2031
• Figure 39: Asia Pacific Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, 2017-2031
• Figure 40: Asia Pacific Urinary Incontinence Treatment Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
• Figure 41: Asia Pacific Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
• Figure 42: Asia Pacific Urinary Incontinence Treatment Devices Market, by Product, 2021 and 2031
• Figure 43: Asia Pacific Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Product, 2022-2031
• Figure 44: Asia Pacific Urinary Incontinence Treatment Devices Market, by Incontinence Type, 2021 and 2031
• Figure 45: Asia Pacific Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Incontinence Type, 2022-2031
• Figure 46: Asia Pacific Urinary Incontinence Treatment Devices Market, by End-user, 2021 and 2031
• Figure 47: Asia Pacific Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by End-user, 2022-2031
• Figure 48: Latin America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, 2017-2031
• Figure 49: Latin America Urinary Incontinence Treatment Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
• Figure 50: Latin America Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
• Figure 51: Latin America Urinary Incontinence Treatment Devices Market, by Product, 2021 and 2031
• Figure 52: Latin America Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Product, 2022-2031
• Figure 53: Latin America Urinary Incontinence Treatment Devices Market, by Incontinence Type, 2021 and 2031
• Figure 54: Latin America Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Incontinence Type, 2022-2031
• Figure 55: Latin America Urinary Incontinence Treatment Devices Market, by End-user, 2021 and 2031
• Figure 56: Latin America Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by End-user, 2022-2031
• Figure 57: Middle East & Africa Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, 2017-2031
• Figure 58: Middle East & Africa Urinary Incontinence Treatment Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
• Figure 59: Middle East & Africa Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
• Figure 60: Middle East & Africa Urinary Incontinence Treatment Devices Market, by Product, 2021 and 2031
• Figure 61: Middle East & Africa Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Product, 2022-2031
• Figure 62: Middle East & Africa Urinary Incontinence Treatment Devices Market, by Incontinence Type, 2021 and 2031
• Figure 63: Middle East & Africa Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Incontinence Type, 2022-2031
• Figure 64: Middle East & Africa Urinary Incontinence Treatment Devices Market, by End-user, 2021 and 2031
• Figure 65: Middle East & Africa Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by End-user, 2022-2031

The report provides revenue of the global urinary incontinence treatment devices market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global urinary incontinence treatment devices market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the urinary incontinence treatment devices market.

The report delves into the competitive landscape of the global urinary incontinence treatment devices market. Key players operating in the global urinary incontinence treatment devices market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global urinary incontinence treatment devices market profiled in this report.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Urinary Incontinence Treatment Devices Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Product Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, 2017-2031
  • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

• 5.1. Technological Advancements
• 5.2. Prevalence of Urinary Incontinence, by Key Region
• 5.3. Regulatory & Reimbursement Scenario, by Country/Region
• 5.4. COVID-19 Impact Analysis

6. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, by Product

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast, by Product, 2017-2031
  • 6.3.1. Urethral Slings
    • 6.3.1.1. Female Slings
    • 6.3.1.2. Male Slings
  • 6.3.2. Electrical Stimulation Devices
    • 6.3.2.1. Implantable
    • 6.3.2.2. Non-implantable
  • 6.3.3. Artificial Urinary Sphincters
  • 6.3.4. Catheters
• 6.4. Market Attractiveness Analysis, by Product

7. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, by Incontinence Type

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast, by Incontinence Type, 2017-2031
  • 7.3.1. Stress Urinary Incontinence
  • 7.3.2. Urge Urinary Incontinence
  • 7.3.3. Mixed Incontinence
  • 7.3.4. Overflow Incontinence
• 7.4. Market Attractiveness Analysis, by Incontinence Type

8. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, by End-user

• 8.1. Introduction & Definition
• 8.2. Key Findings / Developments
• 8.3. Market Value Forecast, by End-user, 2017-2031
  • 8.3.1. Hospitals
  • 8.3.2. Ambulatory Surgery Centers
  • 8.3.3. Clinics
  • 8.3.4. Home Use
• 8.4. Market Attractiveness Analysis, by End-user

9. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, by Region

• 9.1. Key Findings
• 9.2. Market Value Forecast, by Region
  • 9.2.1. North America
  • 9.2.2. Europe
  • 9.2.3. Asia Pacific
  • 9.2.4. Latin America
  • 9.2.5. Middle East & Africa
• 9.3. Market Attractiveness Analysis, by Region

10. North America Urinary Incontinence Treatment Devices Market Analysis and Forecast

• 10.1. Introduction
  • 10.1.1. Key Findings
• 10.2. Market Value Forecast, by Product, 2017-2031
  • 10.2.1. Urethral Slings
    • 10.2.1.1. Female Slings
    • 10.2.1.2. Male Slings
  • 10.2.2. Electrical Stimulation Devices
    • 10.2.2.1. Implantable
    • 10.2.2.2. Non-implantable
  • 10.2.3. Artificial Urinary Sphincters
  • 10.2.4. Catheters
• 10.3. Market Value Forecast, by Incontinence Type, 2017-2031
  • 10.3.1. Stress Urinary Incontinence
  • 10.3.2. Urge Urinary Incontinence
  • 10.3.3. Mixed Incontinence
  • 10.3.4. Overflow Incontinence
• 10.4. Market Value Forecast, by End-user, 2017-2031
  • 10.4.1. Hospitals
  • 10.4.2. Ambulatory Surgery Centers
  • 10.4.3. Clinics
  • 10.4.4. Home Use
• 10.5. Market Value Forecast, by Country, 2017-2031
  • 10.5.1. U.S.
  • 10.5.2. Canada
• 10.6. Market Attractiveness Analysis
  • 10.6.1. By Product
  • 10.6.2. By Incontinence Type
  • 10.6.3. By End-user
  • 10.6.4. By Country

11. Europe Urinary Incontinence Treatment Devices Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast, by Product, 2017-2031
  • 11.2.1. Urethral Slings
    • 11.2.1.1. Female Slings
    • 11.2.1.2. Male Slings
  • 11.2.2. Electrical Stimulation Devices
    • 11.2.2.1. Implantable
    • 11.2.2.2. Non-implantable
  • 11.2.3. Artificial Urinary Sphincters
  • 11.2.4. Catheters
• 11.3. Market Value Forecast, by Incontinence Type, 2017-2031
  • 11.3.1. Stress Urinary Incontinence
  • 11.3.2. Urge Urinary Incontinence
  • 11.3.3. Mixed Incontinence
  • 11.3.4. Overflow Incontinence
• 11.4. Market Value Forecast, by End-user, 2017-2031
  • 11.4.1. Hospitals
  • 11.4.2. Ambulatory Surgery Centers
  • 11.4.3. Clinics
  • 11.4.4. Home Use
• 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 11.5.1. Germany
  • 11.5.2. U.K.
  • 11.5.3. France
  • 11.5.4. Spain
  • 11.5.5. Italy
  • 11.5.6. Rest of Europe
• 11.6. Market Attractiveness Analysis
  • 11.6.1. By Product
  • 11.6.2. By Incontinence Type
  • 11.6.3. By End-user
  • 11.6.4. By Country/Sub-region

12. Asia Pacific Urinary Incontinence Treatment Devices Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast, by Product, 2017-2031
  • 12.2.1. Urethral Slings
    • 12.2.1.1. Female Slings
    • 12.2.1.2. Male Slings
  • 12.2.2. Electrical Stimulation Devices
    • 12.2.2.1. Implantable
    • 12.2.2.2. Non-implantable
  • 12.2.3. Artificial Urinary Sphincters
  • 12.2.4. Catheters
• 12.3. Market Value Forecast, by Incontinence Type, 2017-2031
  • 12.3.1. Stress Urinary Incontinence
  • 12.3.2. Urge Urinary Incontinence
  • 12.3.3. Mixed Incontinence
  • 12.3.4. Overflow Incontinence
• 12.4. Market Value Forecast, by End-user, 2017-2031
  • 12.4.1. Hospitals
  • 12.4.2. Ambulatory Surgery Centers
  • 12.4.3. Clinics
  • 12.4.4. Home Use
• 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 12.5.1. China
  • 12.5.2. Japan
  • 12.5.3. India
  • 12.5.4. Australia & New Zealand
  • 12.5.5. Rest of Asia Pacific
• 12.6. Market Attractiveness Analysis
  • 12.6.1. By Product
  • 12.6.2. By Incontinence Type
  • 12.6.3. By End-user
  • 12.6.4. By Country/Sub-region

13. Latin America Urinary Incontinence Treatment Devices Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast, by Product, 2017-2031
  • 13.2.1. Urethral Slings
    • 13.2.1.1. Female Slings
    • 13.2.1.2. Male Slings
  • 13.2.2. Electrical Stimulation Devices
    • 13.2.2.1. Implantable
    • 13.2.2.2. Non-implantable
  • 13.2.3. Artificial Urinary Sphincters
  • 13.2.4. Catheters
• 13.3. Market Value Forecast, by Incontinence Type, 2017-2031
  • 13.3.1. Stress Urinary Incontinence
  • 13.3.2. Urge Urinary Incontinence
  • 13.3.3. Mixed Incontinence
  • 13.3.4. Overflow Incontinence
• 13.4. Market Value Forecast, by End-user, 2017-2031
  • 13.4.1. Hospitals
  • 13.4.2. Ambulatory Surgery Centers
  • 13.4.3. Clinics
  • 13.4.4. Home Use
• 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 13.5.1. Brazil
  • 13.5.2. Mexico
  • 13.5.3. Rest of Latin America
• 13.6. Market Attractiveness Analysis
  • 13.6.1. By Product
  • 13.6.2. By Incontinence Type
  • 13.6.3. By End-user
  • 13.6.4. By Country/Sub-region

14. Middle East & Africa Urinary Incontinence Treatment Devices Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast, by Product, 2017-2031
  • 14.2.1. Urethral Slings
    • 14.2.1.1. Female Slings
    • 14.2.1.2. Male Slings
  • 14.2.2. Electrical Stimulation Devices
    • 14.2.2.1. Implantable
    • 14.2.2.2. Non-implantable
  • 14.2.3. Artificial Urinary Sphincters
  • 14.2.4. Catheters
• 14.3. Market Value Forecast, by Incontinence Type, 2017-2031
  • 14.3.1. Stress Urinary Incontinence
  • 14.3.2. Urge Urinary Incontinence
  • 14.3.3. Mixed Incontinence
  • 14.3.4. Overflow Incontinence
• 14.4. Market Value Forecast, by End-user, 2017-2031
  • 14.4.1. Hospitals
  • 14.4.2. Ambulatory Surgery Centers
  • 14.4.3. Clinics
  • 14.4.4. Home Use
• 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 14.5.1. GCC Countries
  • 14.5.2. South Africa
  • 14.5.3. Rest of Middle East & Africa
• 14.6. Market Attractiveness Analysis
  • 14.6.1. By Product
  • 14.6.2. By Incontinence Type
  • 14.6.3. By End-user
  • 14.6.4. By Country/Sub-region

15. Competition Landscape

• 15.1. Market Player - Competition Matrix (by tier and size of companies)
• 15.2. Market Share Analysis, by Company, 2021
• 15.3. Company Profiles
  • 15.3.1. C. R. Bard, Inc. (Becton, Dickinson and Company)
    • 15.3.1.1. Company Description
    • 15.3.1.2. Business Overview
    • 15.3.1.3. Financial Overview
    • 15.3.1.4. Strategic Overview
    • 15.3.1.5. SWOT Analysis
  • 15.3.2. Coloplast Group
    • 15.3.2.1. Company Description
    • 15.3.2.2. Business Overview
    • 15.3.2.3. Financial Overview
    • 15.3.2.4. Strategic Overview
    • 15.3.2.5. SWOT Analysis
  • 15.3.3. Promedon Group
    • 15.3.3.1. Company Description
    • 15.3.3.2. Business Overview
    • 15.3.3.3. Financial Overview
    • 15.3.3.4. Strategic Overview
    • 15.3.3.5. SWOT Analysis
  • 15.3.4. A.M.I. GmbH
    • 15.3.4.1. Company Description
    • 15.3.4.2. Business Overview
    • 15.3.4.3. Financial Overview
    • 15.3.4.4. Strategic Overview
    • 15.3.4.5. SWOT Analysis
  • 15.3.5. Ethicon US, LLC. (Johnson & Johnson)
    • 15.3.5.1. Company Description
    • 15.3.5.2. Business Overview
    • 15.3.5.3. Financial Overview
    • 15.3.5.4. Strategic Overview
    • 15.3.5.5. SWOT Analysis
  • 15.3.6. ZSI Surgical Implants S.R.L.
    • 15.3.6.1. Company Description
    • 15.3.6.2. Business Overview
    • 15.3.6.3. Financial Overview
    • 15.3.6.4. Strategic Overview
    • 15.3.6.5. SWOT Analysis
  • 15.3.7. Medtronic plc
    • 15.3.7.1. Company Description
    • 15.3.7.2. Business Overview
    • 15.3.7.3. Financial Overview
    • 15.3.7.4. Strategic Overview
    • 15.3.7.5. SWOT Analysis
  • 15.3.8. InControl Medical LLC
    • 15.3.8.1. Company Description
    • 15.3.8.2. Business Overview
    • 15.3.8.3. Financial Overview
    • 15.3.8.4. Strategic Overview
    • 15.3.8.5. SWOT Analysis
  • 15.3.9. Hollister Incorporated
    • 15.3.9.1. Company Description
    • 15.3.9.2. Business Overview
    • 15.3.9.3. Financial Overview
    • 15.3.9.4. Strategic Overview
    • 15.3.9.5. SWOT Analysis
  • 15.3.10. Atlantic Therapeutics Group Ltd.
    • 15.3.10.1. Company Description
    • 15.3.10.2. Business Overview
    • 15.3.10.3. Financial Overview
    • 15.3.10.4. Strategic Overview
    • 15.3.10.5. SWOT Analysis
  • 15.3.11. B. Braun Melsungen AG
    • 15.3.11.1. Company Description
    • 15.3.11.2. Business Overview
    • 15.3.11.3. Financial Overview
    • 15.3.11.4. Strategic Overview
    • 15.3.11.5. SWOT Analysis
  • 15.3.12. Teleflex Incorporated
    • 15.3.12.1. Company Description
    • 15.3.12.2. Business Overview
    • 15.3.12.3. Financial Overview
    • 15.3.12.4. Strategic Overview
    • 15.3.12.5. SWOT Analysis